This process directly affects the tumor immune microenvironment and enhances host immune surveillance and attack against tumors49 NAT10 enhances mRNA translation of tumor‐associated inflammatory signaling pathways such as interleukin‐6 (IL‐6) and IL‐8 by mediating ac4C modification. The gene discussed is NAT10; the disease is neoplasm.